BIB ProShares Ultra Nasdaq Biotechnology
NASDAQ Biotechnology TR USD

NAV as of 30-Nov-2022

62.0886

4 Week: 55.24 - 62.71

52 Week: 39.29 - 84.88

Latest Closing Price

62.71

Premium / Discount

-0.16

Expense Ratio

0.95%

Investment Objective

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
ProShares
Asset Under Management:
230,141,137
Launch Date:
05/04/2010
Asset Class:
Miscellaneous
Replication Method:
Derivative Based
Number of Holdings:
378
Trading Currency:
USD
Style:
Mid Blend
Region/Sector/Strategy:
N.A / N.A / Equity
Exchange:
NASDAQ

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-22.693.70-6.13
1 Day1.160.000.00
1 Week5.866.440.91
1 Month10.4410.990.95
3 Months19.8826.780.74
6 Months33.1439.780.83
1 Year-21.7957.83-0.38
2 Years-21.3371.46-0.30
3 Years2.9798.580.03
5 Years14.35116.950.12
10 Years5.43190.140.03

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 67.1237160.138266.697613.7964-44.225140.7379-24.362445.504639.7412-5.9111
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
20/09/201027/09/20100.0439

Portfolio Data

Total Number of Holdings: 378

Number of Bond Holdings: 0

Number of Equity Holdings: 376

Total Market Value: 230,141,137

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Nasdaq Bio Index Swap Bnp31.91158,5192,36433,248,805
2Nasdaq Biotechnology Index Swap Societe Generale27.82857,42974028,994,644
3Nasdaq Biotechnology Index Swap Goldman Sachs Inte19.05555,087019,854,052
4Nasdaq Biotechnology Index Swap Citibank Na16.92414,518017,633,302
5Nasdaq Biotechnology Index Swap Ubs Ag12.78113,412013,316,695
6Nasdaq Biotechnology Index Swap Bank Of America Na8.61562,300-3088,976,670

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant8.14
Large31.74
Medium25.47
Small20.13
Micro3.82

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

12.1733

Price/Book*

2.8660

Price/Sales*

1.1412

Price/Cash Flow*

2.1736

Dividend Yield*

0.8411

Growth Measures

Long-Term Earnings

8.9222

Historical Earnings

17.3138

Sales Growth

12.1139

Cash-Flow Growth

15.1226

Book-Value Growth

3.7995

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.